Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	382-386
Number of pages	6
Journal	Journal of Applied Laboratory Medicine
Volume	7
Issue number	1
DOIs	https://doi.org/10.1093/jalm/jfab065
Publication status	Published - 1 Jan 2022

Access to Document

@article{cebf2ae6327247ab871f8369044698e4,

title = "Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19",

author = "J. Amiral and M.H. Busch and S.A.M.E.G. Timmermans and C.P. Reutelingsperger and {van Paassen}, P.",

year = "2022",

month = jan,

day = "1",

doi = "10.1093/jalm/jfab065",

language = "English",

volume = "7",

pages = "382--386",

journal = "Journal of Applied Laboratory Medicine",

issn = "2576-9456",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19

AU - Amiral, J.

AU - Busch, M.H.

AU - Timmermans, S.A.M.E.G.

AU - Reutelingsperger, C.P.

AU - van Paassen, P.

PY - 2022/1/1

Y1 - 2022/1/1

U2 - 10.1093/jalm/jfab065

DO - 10.1093/jalm/jfab065

M3 - Comment/Letter to the editor

C2 - 34213568

SN - 2576-9456

VL - 7

SP - 382

EP - 386

JO - Journal of Applied Laboratory Medicine

JF - Journal of Applied Laboratory Medicine

IS - 1

ER -